Medical and surgical management of coronary artery disease in women

American Journal of Managed Care

Volumn 7, Issue 10, 2001, Pages 951-956

  Alexander, K P ^a   Peterson, E D ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENALAPRIL; ESTROGEN; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; LISINOPRIL; METOPROLOL; PLACEBO; PROGESTERONE; PROPRANOLOL; STREPTOKINASE; SULFINPYRAZONE; SULOCTIDIL; TICLOPIDINE; UNINDEXED DRUG; UROKINASE; VERAPAMIL; VERY LOW DENSITY LIPOPROTEIN;

BODY SIZE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DATA BASE; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; OUTCOMES RESEARCH; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TREATMENT PLANNING;

ANGIOPLASTY; BODY CONSTITUTION; CARDIOVASCULAR AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 0034754534     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Epidemiology of coronary heart disease: The Framingham study
2. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26 year follow-up of the Framingham population
3. AHA health statistics
4. Estimating the likelihood of significant coronary artery disease
5. Risk screening and diagnostic testing in women with suspected coronary artery disease
6. Sex bias in cardiovascular care: Should women be treated more like men?
7. Sex-based differences in early mortality after myocardial infarction: National Retistry of Myocardial Infarction 2 Participants
8. Insights derived from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trials
9. The elderly and women: Are they adequately represented in randomized trials of acute coronary syndromes?
10. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute
11. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
12. Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: Have they been adequately evaluated?
13. Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry
14. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty: A regional prospective study of 13,061 procedures
15. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women
16. Gender differences for coronary angioplasty
17. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty
18. Percutaneous transluminal coronary angioplasty in women compared with men
19. Long-term outcome of women compared with men after successful coronary angioplasty
20. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry
21. Comparison of procedural results and risks of coronary angioplasty in men and women for conditions other than acute myocardial infarction
22. The effect of gender on the outcomes of contemporary percutaneous coronary intervention
23. Better outcome for women compared with men undergoing coronary revascularization: A report from the Bypass Angioplasty Revascularization Investigation (BARI)
24. Impact of gender on coronary bypass operative mortality
25. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery
26. Strafication of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients
27. Increased mortality of women in coronary artery bypass surgery: Evidence for referral bias
28. Coronary artery surgery in women compared with men: Analysis of risks and long-term results
29. Association of sex and physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS)
30. Triglycerides and coronary risk in women and the elderly
31. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
32. Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG, and EPISTENT trials
33. Reproductive factors and risk of myocardial infarction
34. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
35. Hormone therapy to prevent disease and prolong life in post-menopausal women
36. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
37. Estrogen replacement and coronary artery disease
38. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
39. Postmenopausal estrogen and prevention bias
40. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: Prospective cohort study in Gothenburg, Sweden
41. Prior to use of estrogen replacement therapy: Are users healthier than nonusers?
42. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
43. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
44. Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study
45. Impact of evidence based medicine in acute coronary syndromes: Insights from GUSTO IIb
46. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease
47. Differences in the use of procedures between women and men hospitalized for coronary heart disease
48. Sex differences in the management of coronary artery disease
49. Referral to coronary artery revascularization procedures after diagnostic coronary angiography: Evidence for gender bias?
50. Referral patterns for coronary artery disease treatment: Gender bias or good clinical judgement?
51. Sex difference in evaluation and outcome of unstable angina
52. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting
53. Is sex a factor in determining operative risk for aortocoronary bypass graft surgery?
54. The influence of gender on the outcome of coronary artery bypass surgery
55. Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting
56. Examining increased CABG mortality risk in females